Navigation Links
Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds
Date:2/20/2009

th Carnegie Mellon University, will receive $4.7 million to study new ways to reduce infections caused by A. baumannii, C. difficile, and MRSA in hospitalized patients. The project will assess the health and economic impacts of these novel strategies on the prevention and control of infections caused by these multidrug resistant bacteria. A. baumannii is a severe, difficult-to-treat infection in seriously ill hospitalized patients. C. difficile is resistant to numerous drugs and causes serious infection among patients already on antibiotics.
  • The Children's Hospital of Philadelphia (CHOP), collaborating with the University of Pennsylvania, Temple University, Lincoln University and the Philadelphia Public School system, will receive $4.7 million to conduct research aimed at gaining a better understanding of the biological causes of ASD. The studies are based at CHOP's new Center for Autism Research, a collaborative center of emphasis that draws upon faculty and staff at CHOP and Penn in more than ten different disciplines. Researchers will study how recently discovered genes for ASD affect the brain and behavior of children with an ASD, including a study of how genes, brain structure and brain function impact treatment response. Findings from the research project will facilitate the development of more effective tests for diagnosing ASD and will lay the necessary groundwork for major advances in the clinical care of ASD.
  • The University of Pittsburgh, in association with Carnegie Mellon University, will receive $3 million to identify cognitive and genetic mechanisms underlying the abnormal development of brain circuitry associated with ASD. Recent research has demonstrated altered information processing by the brain of persons with autism. Researchers will develop and test a new intervention to enhance thinking capacity and meanin
    '/>"/>

  • SOURCE Pennsylvania Department of Health
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. ISTA Pharmaceuticals New Drug Application for Bepreve(TM) Accepted for Review by U.S. Food and Drug Administration
    2. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
    3. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
    4. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
    5. New AAHC Toolkit Available to Optimize Clinical Research Administration
    6. New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
    7. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
    8. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
    9. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    10. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
    11. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
    (Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... has approved a share repurchase program. The open-ended authorization ... of Mallinckrodt plc ordinary shares. "Funding ... top priorities as we continue to pursue a range ...
    (Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
    Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
    ... (Nasdaq: THOR ), a world leader in device-based ... hearts, today announced that it will report its operating results ... 1. The company will hold a conference call ... all interested parties, at 1:30 p.m., Pacific Daylight Time (4:30 ...
    ... 2011 At the 5 ... in Barcelona, Spain (20-22 October 2011),   Merz Pharmaceuticals ... efficacy and safety of   XEOMIN ® ... Dystonia is a particularly debilitating condition ...
    Cached Medicine Technology:Thoratec Schedules Third Quarter Conference Call, Webcast 2Merz research Shows Long-term Benefits for Patients With Dystonia 2Merz research Shows Long-term Benefits for Patients With Dystonia 3Merz research Shows Long-term Benefits for Patients With Dystonia 4
    (Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
    (Date:1/22/2015)... Nashville, TN (PRWEB) January 22, 2015 Gabe’s Chemo ... Chemo Duck App, the first app ever created for kids with ... all Apple phones and devices, is filled with enjoyable games to ... life and treatments. The free app helps to keep kids entertained, ...
    (Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
    (Date:1/22/2015)... New York (PRWEB) January 22, 2015 ... after Fresenius Medical Care recalled its GranuFlo and NaturaLyte ... multidistrict litigation underway in U.S. District Court, District of ... dated January 20th, the Court has remanded a case ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
    Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
    ... disease requiring creative solutions for diagnosis, quality of life ... San Antonio Breast Cancer Symposium explore these areas. ... Cancer , Abstract #65, Sarah Marshall, M.A. , Although ... breast cancer, they appear to mitigate the mortality risk ...
    ... PartsSource, the nation,s leading,supplier of replacement medical repair parts for ... in Ohio by the Case Western Reserve,University Weatherhead ... placed 14th on this year,s list with a growth rate ... eligible. , "The Weatherhead ...
    ... WASHINGTON, Dec. 12 [The Washington Post ... and Drug Administration and the White House are considering easing ... certain fish. Scientists at the Environmental Protection Agency reportedly ... The move is one of several "midnight" rules and policy ...
    ... treatment decisions, study shows , , FRIDAY, Dec. 12 ... the risk of their breast cancer returning after ... get chemotherapy more difficult, a new study concludes. ... bar chart, based on a standard risk-assessment tool, ...
    ... Care Policy and Legislative Background Assures Strong Leadership for ... , WASHINGTON, Dec. 12 ... nation,s largest cancer treatment and research networks representing approximately ... of former Senator Tom Daschle to lead his newly ...
    ... report from the Institute of Medicine, THE U.S. COMMITMENT ... why a commitment to global health is an important ... the current economic situation. The report describes areas ... incoming administration should strive to meet, and makes specific ...
    Cached Medicine News:Health News:Patient management: Quality of life and beyond 2Health News:Risk Info for Breast Cancer Patients Too Confusing 2Health News:US Oncology Applauds Senator Daschle's Appointment as Director of President-Elect Obama's New White House Office of Health Reform 2
    Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
    The reliable and easy-to-use 3800 pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
    ... 8600 Series Tabletop/Portable Digital Pulse ... tool for patient monitering. From ... the 8600 has earned the ... and is recognized for its ...
    ... Resolve Immersion Oil is a clear, ... throughout most of the UV-VIS spectrum. ... and high viscosity, is non-drying and ... of 1.5150. Resolve contains no PCBs, ...
    Medicine Products: